VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Chronic myeloid leukemia and second-generation tyrosine kinase inhibitors: when, how, and which one?
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Chronic myeloid leukemia and second-generation tyrosine kinase inhibitors: when, how, and which one?
Chronic myeloid leukemia and second-generation tyrosine kinase inhibitors: when, how, and which one? Semin Hematol. 2010 Oct; 47(4):344-53.
View in:
PubMed
subject areas
Antineoplastic Agents
Benzamides
Dasatinib
Drug Resistance, Neoplasm
Fusion Proteins, bcr-abl
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Piperazines
Protein Kinase Inhibitors
Protein-Tyrosine Kinases
Pyrimidines
Thiazoles
authors with profiles
HAGOP M KANTARJIAN
JORGE E CORTES
ELIAS JOSEPH JABBOUR